Clinical Research Directory
Browse clinical research sites, groups, and studies.
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
Sponsor: First Affiliated Hospital of Zhejiang University
Summary
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with pheochromocytoma.
Official title: A Prospective Exploratory Study Evaluating the Diagnostic Usefulness of 18F-mFBG PET Imaging in Pheochromocytoma
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2023-05-01
Completion Date
2026-12
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
18F-MFBG
Patients with pheochromocytoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.
Locations (2)
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China